Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Burgess

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood|May 1, 1992
Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells: c-jun/AP-1 expression versus c-myc transcriptionS Litz-Jackson, A H Miller, G S Burgess, et al.
Leukemia|January 1, 1997
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4E A Williamson, G S Burgess, P Eder, et al.
New Zealand Veterinary Journal|July 1, 1982
Suspected inherited cerebellar neuroaxonal dystrophy in collie sheep dogsR G Clark, W J Hartley, G S Burgess, et al.
Leukemia|September 1, 1995
Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cellsM J Stewart, S Litz-Jackson, G S Burgess, et al.
Leukemia|December 1, 1991
Interleukin-3 dependent mitogenesis in murine cells involves a predominant non-protein kinase C (pKC) dependent pathway for c-myc transcription. Role of a myc expression vector in rescuing pKC dependent mitogenesisT S Nahreini, S Litz-Jackson, G S Burgess, et al.
Experimental Hematology|August 1, 1990
A novel mast cell growth factor (MCGF-3) produced by marrow-adherent cells that synergizes with interleukin 3 and interleukin 4H S Boswell, D Y Mochizuki, G S Burgess, et al.
Leukemia|August 1, 1994
p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogeneK Gharehbaghi, G S Burgess, F R Collart, et al.
Blood|October 6, 2001
Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2V M Gelfanov, G S Burgess, S Litz-Jackson, et al.
Leukemia|July 1, 1990
Role for cyclic AMP in the postreceptor control of cytokine-stimulated stromal cell growth factor productionH G Derigs, G S Burgess, D Klingberg, et al.
Blood|September 15, 1993
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cellsR A Mandanas, D S Leibowitz, K Gharehbaghi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood|May 1, 1992
Dissociation of nuclear events on p21 RAS transformation of FDC-P1 myeloid cells: c-jun/AP-1 expression versus c-myc transcriptionS Litz-Jackson, A H Miller, G S Burgess, et al.
Leukemia|January 1, 1997
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4E A Williamson, G S Burgess, P Eder, et al.
New Zealand Veterinary Journal|July 1, 1982
Suspected inherited cerebellar neuroaxonal dystrophy in collie sheep dogsR G Clark, W J Hartley, G S Burgess, et al.
Leukemia|September 1, 1995
Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cellsM J Stewart, S Litz-Jackson, G S Burgess, et al.
Leukemia|December 1, 1991
Interleukin-3 dependent mitogenesis in murine cells involves a predominant non-protein kinase C (pKC) dependent pathway for c-myc transcription. Role of a myc expression vector in rescuing pKC dependent mitogenesisT S Nahreini, S Litz-Jackson, G S Burgess, et al.
Experimental Hematology|August 1, 1990
A novel mast cell growth factor (MCGF-3) produced by marrow-adherent cells that synergizes with interleukin 3 and interleukin 4H S Boswell, D Y Mochizuki, G S Burgess, et al.
Leukemia|August 1, 1994
p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogeneK Gharehbaghi, G S Burgess, F R Collart, et al.
Blood|October 6, 2001
Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2V M Gelfanov, G S Burgess, S Litz-Jackson, et al.
Leukemia|July 1, 1990
Role for cyclic AMP in the postreceptor control of cytokine-stimulated stromal cell growth factor productionH G Derigs, G S Burgess, D Klingberg, et al.
Blood|September 15, 1993
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cellsR A Mandanas, D S Leibowitz, K Gharehbaghi, et al.
Pageof 2